AlphaTON’s Cyncado Therapeutics teams up with Australia’s ADDRI to launch a groundbreaking investigator-initiated mesothelioma trial of TT-4, perfectly complementing ongoing U.S. clinical efforts and accelerating the fight against cancer
Browsing: ADDRI